MISSISSAUGA, ONTARIO--(Marketwire - July 08, 2008) - Covalon Technologies Ltd. (TSX VENTURE: COV) is pleased to announce that it has reached a significant milestone in its research as part of a Development Agreement with one of the world's largest vascular access device companies.
